{
    "references": [
        {
            "bibentry": "Radmark, O, Samuelsson, B. Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer. J Intern Med 2010; 268: 5–14. PMID: 20497297",
            "process_entry": "True",
            "doi": "10.1111/j.1365-2796.2010.02246.x",
            "pmid": "20497297",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Koeberle, A, Werz, O. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders. Biochem Pharmacol 2015; 98: 1–15. PMID: 26123522",
            "process_entry": "True",
            "doi": "10.1016/j.bcp.2015.06.022",
            "pmid": "26123522",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "El Mansouri, FE, Nebbaki, SS, Kapoor, M, et al. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1beta-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes. Arthritis Res Ther 2014; 16: R113. PMID: 24886859",
            "process_entry": "True",
            "doi": "10.1186/ar4564",
            "pmid": "24886859",
            "pmcid": "PMC4060543",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Kudo, I, Murakami, M. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol 2005; 38: 633–8. PMID: 16336776",
            "process_entry": "True",
            "doi": "10.5483/bmbrep.2005.38.6.633",
            "pmid": "16336776",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Sampey, AV, Monrad, S, Crofford, LJ. Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2. Arthritis Res Ther 2005; 7: 114–7. PMID: 15899061",
            "process_entry": "True",
            "doi": "10.1186/ar1748",
            "pmid": "15899061",
            "pmcid": "PMC1174970",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Funk, CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (New York, NY) 2001; 294: 1871–5.",
            "process_entry": "True",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Ruan, D, So, SP. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo. Life Sci 2014; 116: 43–50. PMID: 25139833",
            "process_entry": "True",
            "doi": "10.1016/j.lfs.2014.07.042",
            "pmid": "25139833",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Graham, DJ, Campen, D, Hui, R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet (London, England) 2005; 365: 475–81.",
            "process_entry": "True",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Cheng, Y, Wang, M, Yu, Y, et al. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Investig 2006; 116: 1391–9. PMID: 16614756",
            "process_entry": "True",
            "doi": "10.1172/JCI27540",
            "pmid": "16614756",
            "pmcid": "PMC1435722",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Lu, D, Han, C, Wu, T. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis. Oncogene 2012; 31: 842–57. PMID: 21743491",
            "process_entry": "True",
            "doi": "10.1038/onc.2011.287",
            "pmid": "21743491",
            "pmcid": "PMC3193853",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Doudna, JA, Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (New York, NY) 2014; 346: 1258096.",
            "process_entry": "True",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Komor, AC, Badran, AH, Liu, DR. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell 2017; 169: 559.",
            "process_entry": "True",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Wang, H, La Russa, M, Qi, LS. CRISPR/Cas9 in genome editing and beyond. Annu Rev Biochem 2016; 85: 227–64. PMID: 27145843",
            "process_entry": "True",
            "doi": "10.1146/annurev-biochem-060815-014607",
            "pmid": "27145843",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Rodrigues, GMC, Gaj, T, Adil, MM, et al. Defined and scalable differentiation of human oligodendrocyte precursors from pluripotent stem cells in a 3D culture system. Stem Cell Rep 2017; 8: 1770–83.",
            "process_entry": "True",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Mukherjee, S, Zhang, T, Lacko, LA, et al. Derivation and characterization of a UCP1 reporter human ES cell line. Stem Cell Res 2018; 30: 12–21. PMID: 29777802",
            "process_entry": "True",
            "doi": "10.1016/j.scr.2018.04.007",
            "pmid": "29777802",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Wang, Y, Chang, L, Zhai, J, et al. Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism. J Cell Mol Med 2017; 21: 3214–23. PMID: 28557353",
            "process_entry": "True",
            "doi": "10.1111/jcmm.13225",
            "pmid": "28557353",
            "pmcid": "PMC5706564",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Baker, O, Tsurkan, S, Fu, J, et al. The contribution of homology arms to nuclease-assisted genome engineering. Nucleic Acids Res 2017; 45: 8105–15. PMID: 28582546",
            "process_entry": "True",
            "doi": "10.1093/nar/gkx497",
            "pmid": "28582546",
            "pmcid": "PMC5570031",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Cho, YS, Kim, BS, Sim, CK, et al. Establishment of IL-7 expression reporter human cell lines, and their feasibility for high-throughput screening of IL-7-upregulating chemicals. PLoS One 2016; 11: e0161899. PMID: 27589392",
            "process_entry": "True",
            "doi": "10.1371/journal.pone.0161899",
            "pmid": "27589392",
            "pmcid": "PMC5010243",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Chen, Z, Tang, N, Wang, X, Chen, Y. The activity of the carbamoyl phosphate synthase 1 promoter in human liver-derived cells is dependent on hepatocyte nuclear factor 3-beta. J Cell Mol Med 2017; 21: 2036–45. PMID: 28272778",
            "process_entry": "True",
            "doi": "10.1111/jcmm.13123",
            "pmid": "28272778",
            "pmcid": "PMC5571533",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Lackner, DH, Carre, A, Guzzardo, PM, et al. A generic strategy for CRISPR-Cas9-mediated gene tagging. Nat Commun 2015; 6: 10237. PMID: 26674669",
            "process_entry": "True",
            "doi": "10.1038/ncomms10237",
            "pmid": "26674669",
            "pmcid": "PMC4703899",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Chari, R, Mali, P, Moosburner, M, Church, GM. Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach. Nat Methods 2015; 12: 823–6. PMID: 26167643",
            "process_entry": "True",
            "doi": "10.1038/nmeth.3473",
            "pmid": "26167643",
            "pmcid": "PMC5292764",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Bae, S, Kweon, J, Kim, HS, Kim, JS. Microhomology-based choice of Cas9 nuclease target sites. Nat Methods 2014; 11: 705–6. PMID: 24972169",
            "process_entry": "True",
            "doi": "10.1038/nmeth.3015",
            "pmid": "24972169",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Mali, P, Yang, L, Esvelt, KM, et al. RNA-guided human genome engineering via Cas9. Science (New York, NY) 2013; 339: 823–6.",
            "process_entry": "True",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Frock, RL, Hu, J, Meyers, RM, et al. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat Biotechnol 2015; 33: 179–86. PMID: 25503383",
            "process_entry": "True",
            "doi": "10.1038/nbt.3101",
            "pmid": "25503383",
            "pmcid": "PMC4320661",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Kosicki, M, Tomberg, K, Bradley, A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol 2018; 36: 765–71. PMID: 30010673",
            "process_entry": "True",
            "doi": "10.1038/nbt.4192",
            "pmid": "30010673",
            "pmcid": "PMC6390938",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Haapaniemi, E, Botla, S, Persson, J, et al. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med 2018; 24: 927–30. PMID: 29892067",
            "process_entry": "True",
            "doi": "10.1038/s41591-018-0049-z",
            "pmid": "29892067",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Ihry, RJ, Worringer, KA, Salick, MR, et al. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med 2018; 24: 939–46. PMID: 29892062",
            "process_entry": "True",
            "doi": "10.1038/s41591-018-0050-6",
            "pmid": "29892062",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Nishizawa, N, Ito, Y, Eshima, K, et al. Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice. J Hepatol 2018; 69: 110–20. PMID: 29458169",
            "process_entry": "True",
            "doi": "10.1016/j.jhep.2018.02.009",
            "pmid": "29458169",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Lu, D, Han, C, Wu, T. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression. Gastroenterology 2011; 140: 2084–94. PMID: 21354147",
            "process_entry": "True",
            "doi": "10.1053/j.gastro.2011.02.056",
            "pmid": "21354147",
            "pmcid": "PMC3109169",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Kock, A, Larsson, K, Bergqvist, F, et al. Inhibition of microsomal prostaglandin E synthase-1 in cancer-associated fibroblasts suppresses neuroblastoma tumor growth. EBioMedicine 2018; 32: 84–92. PMID: 29804818",
            "process_entry": "True",
            "doi": "10.1016/j.ebiom.2018.05.008",
            "pmid": "29804818",
            "pmcid": "PMC6021299",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Larsson, K, Kock, A, Idborg, H, et al. COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset. Proc Natl Acad Sci USA 2015; 112: 8070–5. PMID: 26080408",
            "process_entry": "True",
            "doi": "10.1073/pnas.1424355112",
            "pmid": "26080408",
            "pmcid": "PMC4491767",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Coulombe, F, Jaworska, J, Verway, M, et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. Immunity 2014; 40: 554–68. PMID: 24726877",
            "process_entry": "True",
            "doi": "10.1016/j.immuni.2014.02.013",
            "pmid": "24726877",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Bahia, MS, Katare, YK, Silakari, O, et al. Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates. Med Res Rev 2014; 34: 825–55. PMID: 25019142",
            "process_entry": "True",
            "doi": "10.1002/med.21306",
            "pmid": "25019142",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Samuelsson, B, Morgenstern, R, Jakobsson, PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 2007; 59: 207–24. PMID: 17878511",
            "process_entry": "True",
            "doi": "10.1124/pr.59.3.1",
            "pmid": "17878511",
            "xmlid": "CIT0034"
        }
    ],
    "localid": "MED-30879343",
    "doi": "10.1080/14756366.2019.1587416",
    "pmid": "10.1080/14756366.2019.1587416",
    "pmcid": "30879343",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30879343/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0001",
                "rp_string": "1–3",
                "pl_string": "1–3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,214)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 1,
                "xref_id": "",
                "pl_string": "1–3",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,214)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 2,
                "xref_id": "",
                "pl_string": "1–3",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,214)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0001",
                "rp_string": "1–3",
                "pl_string": "1–3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,214)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),216,191)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0005",
                "rp_string": "5–7",
                "pl_string": "5–7",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),676,86)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 6,
                "xref_id": "",
                "pl_string": "5–7",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),676,86)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 7,
                "xref_id": "",
                "pl_string": "5–7",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),676,86)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0005",
                "rp_string": "5–7",
                "pl_string": "5–7",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),676,86)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),876,246)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_xpath": "substring(string(/article/body/sec[1]/p[1]),1018,3)",
                "pl_string": ")8,"
            },
            {
                "n_rp": 10,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),876,246)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_xpath": "substring(string(/article/body/sec[1]/p[1]),1018,3)",
                "pl_string": ")8,"
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,339)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,339)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,148)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 17,
                "xref_id": "CIT0011",
                "rp_string": "11–13",
                "pl_string": "11–13",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),831,191)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 15,
                "xref_id": "",
                "pl_string": "11–13",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),831,191)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 16,
                "xref_id": "",
                "pl_string": "11–13",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),831,191)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 17,
                "xref_id": "CIT0011",
                "rp_string": "11–13",
                "pl_string": "11–13",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),831,191)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 21,
                "xref_id": "CIT0014",
                "rp_string": "14–16",
                "pl_string": "14–16",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1023,197)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 19,
                "xref_id": "",
                "pl_string": "14–16",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1023,197)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 20,
                "xref_id": "",
                "pl_string": "14–16",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1023,197)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 21,
                "xref_id": "CIT0014",
                "rp_string": "14–16",
                "pl_string": "14–16",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1023,197)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1221,144)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),580,117)",
                "containers_title": [
                    "Materials and methods",
                    "RNA extraction and real-time RT-PCR analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0019",
                "rp_string": "19",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),698,195)",
                "containers_title": [
                    "Materials and methods",
                    "RNA extraction and real-time RT-PCR analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0020",
                "rp_string": "20–22",
                "pl_string": "20–22",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref",
                "pl_xpath": "/article/body/sec[4]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),364,154)",
                "containers_title": [
                    "Discussion"
                ]
            },
            {
                "n_rp": 26,
                "xref_id": "",
                "pl_string": "20–22",
                "pl_xpath": "/article/body/sec[4]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),364,154)",
                "containers_title": [
                    "Discussion"
                ]
            },
            {
                "n_rp": 27,
                "xref_id": "",
                "pl_string": "20–22",
                "pl_xpath": "/article/body/sec[4]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),364,154)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0020",
                "rp_string": "20–22",
                "pl_string": "20–22",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref",
                "pl_xpath": "/article/body/sec[4]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),364,154)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 29,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),328,170)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 30,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),1,301)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "In current CRISPR technology research, some scholars have discovered substantial fragment deletions or other fragment deletions, chromosomal translocations, and other complex DNA recombination problems near the Cas9 cleavage site24,25, particularly the deletion of the tumour suppressor gene p5326,27. We were concerned that cell proliferation may be impaired after using gene editing techniques, thereby leading to false results in the use of reporter cells for small molecule drug screening. To detect the presence or absence of this possibility, we tested the cell proliferation ability of the reporter cells and found that cell proliferation in the reporter and WT cells were the same (statistically meaningless). Thus, the possibility of editing techniques affecting cell proliferation was initially ruled out.",
                "pl_xpath": "/article/body/sec[4]/p[4]"
            },
            {
                "n_rp": 31,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),1,301)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "In current CRISPR technology research, some scholars have discovered substantial fragment deletions or other fragment deletions, chromosomal translocations, and other complex DNA recombination problems near the Cas9 cleavage site24,25, particularly the deletion of the tumour suppressor gene p5326,27. We were concerned that cell proliferation may be impaired after using gene editing techniques, thereby leading to false results in the use of reporter cells for small molecule drug screening. To detect the presence or absence of this possibility, we tested the cell proliferation ability of the reporter cells and found that cell proliferation in the reporter and WT cells were the same (statistically meaningless). Thus, the possibility of editing techniques affecting cell proliferation was initially ruled out.",
                "pl_xpath": "/article/body/sec[4]/p[4]"
            },
            {
                "n_rp": 32,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),1,301)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "In current CRISPR technology research, some scholars have discovered substantial fragment deletions or other fragment deletions, chromosomal translocations, and other complex DNA recombination problems near the Cas9 cleavage site24,25, particularly the deletion of the tumour suppressor gene p5326,27. We were concerned that cell proliferation may be impaired after using gene editing techniques, thereby leading to false results in the use of reporter cells for small molecule drug screening. To detect the presence or absence of this possibility, we tested the cell proliferation ability of the reporter cells and found that cell proliferation in the reporter and WT cells were the same (statistically meaningless). Thus, the possibility of editing techniques affecting cell proliferation was initially ruled out.",
                "pl_xpath": "/article/body/sec[4]/p[4]"
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),1,301)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 34,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),178,338)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "mPGES-1 is a terminal enzyme for the synthesis of PGE2, and targeting inhibition of mPGES-1 does not cause changes in other prostaglandins, and thus, has research significance. At present, research on mPGES-1 is increasing, and it has been reported that the inhibition of targeting mPGES-1 has many effects: promoting liver repair after injury in mice28, inhibiting the progression and occurrence of experimental cholangiocarcinoma29, inhibiting the growth of neuroblastoma30,31, and enhancing antiviral immunity32. Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,34.",
                "pl_xpath": "/article/body/sec[4]/p[5]"
            },
            {
                "n_rp": 35,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),178,338)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "mPGES-1 is a terminal enzyme for the synthesis of PGE2, and targeting inhibition of mPGES-1 does not cause changes in other prostaglandins, and thus, has research significance. At present, research on mPGES-1 is increasing, and it has been reported that the inhibition of targeting mPGES-1 has many effects: promoting liver repair after injury in mice28, inhibiting the progression and occurrence of experimental cholangiocarcinoma29, inhibiting the growth of neuroblastoma30,31, and enhancing antiviral immunity32. Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,34.",
                "pl_xpath": "/article/body/sec[4]/p[5]"
            },
            {
                "n_rp": 36,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),178,338)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "mPGES-1 is a terminal enzyme for the synthesis of PGE2, and targeting inhibition of mPGES-1 does not cause changes in other prostaglandins, and thus, has research significance. At present, research on mPGES-1 is increasing, and it has been reported that the inhibition of targeting mPGES-1 has many effects: promoting liver repair after injury in mice28, inhibiting the progression and occurrence of experimental cholangiocarcinoma29, inhibiting the growth of neuroblastoma30,31, and enhancing antiviral immunity32. Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,34.",
                "pl_xpath": "/article/body/sec[4]/p[5]"
            },
            {
                "n_rp": 37,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),178,338)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "mPGES-1 is a terminal enzyme for the synthesis of PGE2, and targeting inhibition of mPGES-1 does not cause changes in other prostaglandins, and thus, has research significance. At present, research on mPGES-1 is increasing, and it has been reported that the inhibition of targeting mPGES-1 has many effects: promoting liver repair after injury in mice28, inhibiting the progression and occurrence of experimental cholangiocarcinoma29, inhibiting the growth of neuroblastoma30,31, and enhancing antiviral immunity32. Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,34.",
                "pl_xpath": "/article/body/sec[4]/p[5]"
            },
            {
                "n_rp": 38,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),178,338)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "mPGES-1 is a terminal enzyme for the synthesis of PGE2, and targeting inhibition of mPGES-1 does not cause changes in other prostaglandins, and thus, has research significance. At present, research on mPGES-1 is increasing, and it has been reported that the inhibition of targeting mPGES-1 has many effects: promoting liver repair after injury in mice28, inhibiting the progression and occurrence of experimental cholangiocarcinoma29, inhibiting the growth of neuroblastoma30,31, and enhancing antiviral immunity32. Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,34.",
                "pl_xpath": "/article/body/sec[4]/p[5]"
            }
        ],
        [
            {
                "n_rp": 39,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),517,203)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "mPGES-1 is a terminal enzyme for the synthesis of PGE2, and targeting inhibition of mPGES-1 does not cause changes in other prostaglandins, and thus, has research significance. At present, research on mPGES-1 is increasing, and it has been reported that the inhibition of targeting mPGES-1 has many effects: promoting liver repair after injury in mice28, inhibiting the progression and occurrence of experimental cholangiocarcinoma29, inhibiting the growth of neuroblastoma30,31, and enhancing antiviral immunity32. Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,34.",
                "pl_xpath": "/article/body/sec[4]/p[5]"
            },
            {
                "n_rp": 40,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),517,203)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "mPGES-1 is a terminal enzyme for the synthesis of PGE2, and targeting inhibition of mPGES-1 does not cause changes in other prostaglandins, and thus, has research significance. At present, research on mPGES-1 is increasing, and it has been reported that the inhibition of targeting mPGES-1 has many effects: promoting liver repair after injury in mice28, inhibiting the progression and occurrence of experimental cholangiocarcinoma29, inhibiting the growth of neuroblastoma30,31, and enhancing antiviral immunity32. Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,34.",
                "pl_xpath": "/article/body/sec[4]/p[5]"
            },
            {
                "n_rp": 41,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),517,203)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "mPGES-1 is a terminal enzyme for the synthesis of PGE2, and targeting inhibition of mPGES-1 does not cause changes in other prostaglandins, and thus, has research significance. At present, research on mPGES-1 is increasing, and it has been reported that the inhibition of targeting mPGES-1 has many effects: promoting liver repair after injury in mice28, inhibiting the progression and occurrence of experimental cholangiocarcinoma29, inhibiting the growth of neuroblastoma30,31, and enhancing antiviral immunity32. Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,34.",
                "pl_xpath": "/article/body/sec[4]/p[5]"
            }
        ],
        [
            {
                "n_rp": 42,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),517,203)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ]
    ]
}